Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer Prospective, Randomized, Open, Multicenter Phase III Trial to Investigate the Efficacy of Active Post-resection/Ablation Therapy in Patients With Metastatic Colorectal Cancer

NCT05008809 is registered in ClinicalTrials.gov with Dominik Paul Modest as lead sponsor.

NCT NCT05008809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05008809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer Prospective, Randomized, Open, Multicenter Phase III Trial to Investigate the Efficacy of Active Post-resection/Ablation Therapy in Patients With Metastatic Colorectal Cancer
Lead sponsor
Dominik Paul Modest
Phase
Phase 3
Overall status
Recruiting
Start date
December 6, 2021
Completion date
November 30, 2030
Enrollment
507 (estimated)
Sites
79

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer